Cure Ventures Launches with the Close of Inaugural $350 Million Fund
Cure Ventures (“Cure”), a life sciences venture capital firm focusing on company formation around groundbreaking curative technologies, today announced the closing of its inaugural fund, Cure Ventures Fund I, L.P., at its targeted hard-cap of $350 million in capital commitments.
Cure Ventures Launches with the Close of Inaugural $350 Million Fund Read More »